Investigational Drug Information for HEC96719
✉ Email this page to a colleague
What is the development status for investigational drug HEC96719?
HEC96719 is an investigational drug.
There have been 4 clinical trials for HEC96719.
The most recent clinical trial was a Phase 1 trial, which was initiated on November 15th 2021.
The most common disease conditions in clinical trials are Non-alcoholic Fatty Liver Disease, Fatty Liver, and Liver Diseases. The leading clinical trial sponsors are Sunshine Lake Pharma Co., Ltd. and [disabled in preview].
Summary for HEC96719
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 6 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 1 (2021-11-15) |
| Vendors | 5 |
Recent Clinical Trials for HEC96719
| Title | Sponsor | Phase |
|---|---|---|
| A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis | Sunshine Lake Pharma Co., Ltd. | Phase 2 |
| Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult Subjects | Sunshine Lake Pharma Co., Ltd. | Phase 1 |
| The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects | Sunshine Lake Pharma Co., Ltd. | Phase 1 |
Clinical Trial Summary for HEC96719
Top disease conditions for HEC96719
Top clinical trial sponsors for HEC96719
US Patents for HEC96719
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
